Chronic fatigue syndrome: A review;La sindrome da stanchezza cronica

Recenti Progressi in Medicina

Volumn 95, Issue 11, 2004, Pages

  Carlo Stella, Nicoletta ^a   Lorusso, Lorenzo ^b   Candura, Stefano M ^a   Cuccia, Mariaclara ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b Mellino Mellini Hospital Trust   (Italy)

Author keywords

Chronic fatigue syndrome; Cytokines; Immunogenetics sickness behavior

Indexed keywords

ACICLOVIR; AMPLIGEN; ANTIDEPRESSANT AGENT; ANTIVIRUS AGENT; ANXIOLYTIC AGENT; AZATHIOPRINE; CORTISONE; CYTOKINE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT;

CENTRAL NERVOUS SYSTEM; CHRONIC FATIGUE SYNDROME; CYTOKINE PRODUCTION; DISABILITY; DISEASE CLASSIFICATION; HUMAN; ILLNESS BEHAVIOR; IMMUNOGENETICS; IMMUNOLOGY; INCIDENCE; INFECTION; ITALY; NEUROLOGY; PERIPHERAL NERVOUS SYSTEM; PERSIAN GULF SYNDROME; REVIEW;

ACYCLOVIR; ADOLESCENT; ADULT; AGE FACTORS; ANTIVIRAL AGENTS; CROSS-SECTIONAL STUDIES; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PSYCHOTROPIC DRUGS; SEX FACTORS;

EID: 19644400779     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Henderson DA, Shelokov A. Epidemic neuromiasthenia-clinical syndrome NEJM 1959; 260: 757-64.
2. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108: 387-89.
3. Sharpe MC, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A, et al. A report. Chronic fatigue syndrome: guidelines for research. J R Soc Med 1991; 84: 118-21.
4. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994; 121: 953-59.
5. De Meirleir K, Peterson DL, De Becker P, et al. From laboratory to patient care. In: Chronic fatigue syndrome: a biological approach. Boca Raton: CRC Press 2002.
6. Reeves WC, Lloyd A, Vernon SD, et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res 2003; 3: 25.
7. Klonoff DC. Chronic fatigue syndrome. Clin Infect Dis 1992; 15: 812-23.
8. Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, et al. A community-based study of chronic fatigue syndrome. Arch Intern Med 1999; 159: 2129-37.
9. Lloyd AR, Hickie I, Boughton CR, Spencer O, Wakefield D. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust 1990; 153: 522-28.
10. Arpino C, Carrieri MP, Valesini G, Pizzigallo E, Rovere P, Tirelli U. Idiopathic chronic fatigue and chronic fatigue sindrome: a comparison of two case-definitions. Ann Ist Sup San 1999; 35: 435-41.
11. Wessely S, Chalder T, Hirsch S, Wallace P, Wright D. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health. 1997; 87: 1449-55.
12. Bazelmans E, Vercoulen JH, Galama JM, van Weel C, van der Meer JW, Bleijenberg G. Prevalence of chronic fatigue syndrome and primary fibromyalgia syndrome in The Netherlands. Ned Tijdschr Geneeskd 1997; 141: 1520-23.
13. Gray GC, Reed RJ, Kaiser KS, Smith TC, Gastanaga VM. Self-reported symptoms and medical conditions among 11,868 Gulf War-era veterans: the Seabee Health Study. Am J Epidemiol 2002; 155: 1033-44.
14. Tournier JN, Drouet E, Jouan A. The Gulf war syndrome. Presse Méd 2002; 31: 3-9.
15. Reyes M, Gary HE Jr, Dobbins JG, Randall B, Steele L, Fukuda K, et al. Surveillance for chronic fatigue syndrome - four U.S. cities, September 1989 through August 1993.MMWR CDC Surveill Summ 1997; 46: 1-13.
16. Natelson BH, Haghighi MH, Ponzio NM. Evidence for the presence of immune dysfunction in chronic fatigue syndrome. Clin Diagn Lab Immunol 2002; 9: 747-52.
17. Patarca R. Cytokines and chronic fatigue syndrome. Ann N Y Acad Sci 2001; 933: 185-200.
18. Skowera A, Stewart E, Davis ET, Cleare AJ, Unwin C, Hull L, et al. Antinuclear autoantibodies (ANA) in Gulf War-related illness and chronic fatigue syndrome (CFS) patients. Clin Exp Immunol 2002; 129: 354-8.
19. Gupta S, Vayuvegula B. A comprehensive immunological analysis in chronic fatigue syndrome. Scand J Immunol 1991; 33: 319-27.
20. Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73: 1224-34.
21. Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, et al. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab 2001; 86: 3545-54.
22. Kelley KW, Bluthe RM, Dantzer R, Zhou JH, Shen WH, Johnson RW, et al. Cytokine-induced sickness behavior. Brain Behav Immun 2003; 17: S112.
23. Tirelli U, Chierichetti F, Tavio M, Simonelli C, Bianchin G, Zanco P, et al. Brain positron emission tomography (PET) in chronic fatigue sindrome: preliminary data. Am J Med 1998; 105: 54s-58s.
24. Dantzer R. Innate immunity at the forefront of psychoneuroimmunology. Brain Behav Immun 2004; 18: 1-6.
25. Walsh CM, Zainal NZ, Middleton SJ, et al. A family history of chronic fatigue syndrome. Psych Gen 2001; 11: 123-28.
26. Hickie I, Kirk K, Martin N, et al. Unique genetic and environmental determinants of prolonged fatigue: a twin study. Psychol Med 1999; 29: 259-68.
27. Vernon S, Unger E, Dimulescu I, et al. Utility of blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers 2002; 18: 192-99.
28. Whistler T, Unger ER, Nisenbaum R, Vernon S. Integration of gene expression, clinical and epidemiologic data to characterize chronic fatigue syndrome. J Translational Med 2003; 1: 10.
29. Keller RH, Lane JL, Klimas N, Reiter WM, Fletcher MA, van Riel F, Morgan R. Association between HLA class II antigens and the chronic fatigue immune dysfunction syndrome. Clin Infect Dis 1994; 18: s154-56.
30. Underbill JA, Mahalingam M, Peakman M, Wessely S. Lack of association between HLA genotype and chronic fatigue syndrome. Eur J Immunogenet 2001; 28: 425-28.
31. Klonoff DC. Chronic fatigue syndrome. Clin Infect Dis 1992; 15: 812-23.
32. Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramirez G. Interventions for the treatment and management of chronic fatigue syndrome: A systematic review. JAMA 2001; 286: 1360-68.
33. De Becker P, McGregor NR, DeSmet K, De Meirleir K. Current advances in CFS therapy. In: Chronic fatigue syndrome: a biological approach. Boca Raton: CRC Press 2002.